NCT01199133View on ClinicalTrials.gov

Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis in Adolescents and Children

PHASE3TerminatedINTERVENTIONAL

Enrollment

471

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

January 31, 2011

Study Completion Date

September 30, 2011

Conditions

Allergic Rhinitis Due to Dust Mite

Interventions

DRUG

300 IR house dust mites allergen extract tablet

One sublingual tablet daily for one year.

DRUG

Placebo tablet

One sublingual tablet daily for one year.

Sponsors

Lead Sponsor

Stallergenes Greer

All Listed Sponsors

lead

Stallergenes Greer

INDUSTRY